IgG4-RD or immunoglobulin G4-related disease can affect almost any organ in the body. It’s manifestation is most often seen in the pancreas – autoimmune pancreatitis – or in the bile ducts and liver, where it is known as IgG4-related sclerosing cholangitis or IgG4-associated cholangitis.
The dramatic response to steroids makes autoimmune pancreatitis (AIP) unique among pancreatic disorders, but many cases are steroid-resistant, and relapse is common after steroid withdrawal. Mayo Clinic gastroenterologist, Dr. Mark Topazian discusses a recent study which shows that rituximab maintenance therapy can prolong remission.
So what are some "take home” messages from this study?
Meet other people talking about autoimmune pancreatitis, including other IgG4-related diseases on Mayo Clinic Connect. Join the conversation, share experiences, ask questions, and discover your support network...